Your session is about to expire
← Back to Search
Embolization Agent
the Terumo Hydropearl® microspheres device for Osteoarthritis (GAE Trial)
N/A
Waitlist Available
Led By Osmanuddin Ahmed, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
GAE Trial Summary
This trial will test a new pain-relief procedure for people with osteoarthritis in their knees.
Eligible Conditions
- Osteoarthritis of the Knee
GAE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
KOOS Scale
Oswestry Disability Index
WOMAC Scale
Secondary outcome measures
KOOS for Knee Pain and Dysfunction
Opiate Usage
Oswestry Disability Index for Knee Pain and Dysfunction
+4 moreGAE Trial Design
1Treatment groups
Experimental Treatment
Group I: GAE ArmExperimental Treatment1 Intervention
Patients who meet study eligibility will be scheduled to undergo the Genicular Artery Embolization procedure and will subsequent be followed for 12 months after their procedure.
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,012 Previous Clinical Trials
734,065 Total Patients Enrolled
2 Trials studying Osteoarthritis
433 Patients Enrolled for Osteoarthritis
Osmanuddin Ahmed, MDPrincipal InvestigatorUniversity of Chicago
1 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: GAE Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger